Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Liu, Tian Yu ^a,c   Tan, Zhu Jun ^a,c   Jiang, Lin ^a,c   Gu, Jian Feng ^b   Wu, Xiang Song ^a,c   Cao, Yang ^a,c   Li, Mao Lan ^a,c   Wu, Ke Jin ^a   Liu, Ying Bin ^a,c  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Affiliated Changshu Hospital of Suzhou University   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Curcumin; Gallbladder carcinoma GBC SD cell; Proliferation

Indexed keywords

CASPASE 3; CURCUMIN; PROTEIN BAX; PROTEIN BCL 2;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; GALLBLADDER CARCINOMA; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; S PHASE CELL CYCLE CHECKPOINT;

EID: 84879448340     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-64     Document Type: Article

References (38)

1. Kaza RK, Gulati M, Wig JD, Chawla YK. Evaluation of gall bladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography. Australas Radiol 2006, 50(3):212-217. 10.1111/j.1440-1673.2006.01564.x, 16732816.
2. Tan Z, Li M, Wu W, Zhang L, Ding Q, Wu X, Mu J, Liu Y. NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Mol Cell Biochem 2012, 369(1-2):27-33.
3. Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y, Cheng DQ, Weng WH, Wu XS, Fei XZ, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009, 281(1):71-81. 10.1016/j.canlet.2009.02.020, 19299076.
4. Wang JD, Shi WB, Shen J, Zhuang PY, Quan ZW, Wang XF, Zhou XP, Li SG, Liu YB, Yang Y. Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer. Med Oncol 2011, 28(Suppl 1):S295-300.
5. Dong P, He XW, Gu J, Wu WG, Li ML, Yang JH, Zhang L, Ding QC, Lu JH, Mu JS, et al. Vimentin significantly promoted gallbladder carcinoma metastasis. Chin Med J (Engl) 2011, 124(24):4236-4244.
6. Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol 2008, 34(3):306-312. 10.1016/j.ejso.2007.07.206, 17964753.
7. Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, Hiraoka N. Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. Br J Surg 2011, 98(1):117-123. 10.1002/bjs.7262, 21136566.
8. Malka D, Boige V, Dromain C, Debaere T, Pocard M, Ducreux M. Biliary tract neoplasms: update 2003. Curr Opin Oncol 2004, 16(4):364-371. 10.1097/01.cco.0000129679.49651.50, 15187892.
9. Ye F, Zhang GH, Guan BX, Xu XC. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World J Gastroenterol 2012, 18(2):126-135. 10.3748/wjg.v18.i2.126, 3257439, 22253518.
10. Saha A, Kuzuhara T, Echigo N, Fujii A, Suganuma M, Fujiki H. Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of "growth arrest and DNA damage inducible genes 45 and 153". Biol Pharm Bull 2010, 33(8):1291-1299. 10.1248/bpb.33.1291, 20686221.
11. Kumaravel M, Sankar P, Latha P, Benson CS, Rukkumani R. Antiproliferative effects of an analog of curcumin in Hep-2 cells: a comparative study with curcumin. Nat Prod Commun 2013, 8(2):183-186.
12. Guimaraes MR, Coimbra LS, de Aquino SG, Spolidorio LC, Kirkwood KL, Rossa C. Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. J Periodontal Res 2011, 46(2):269-279. 10.1111/j.1600-0765.2010.01342.x, 3086370, 21306385.
13. Debnath S, Saloum D, Dolai S, Sun C, Averick S, Raja K, Fata JE. Dendrimer-curcumin 2013, A Water Soluble and Effective Cytotoxic Agent against Breast Cancer Cell Lines. Anticancer Agents Med Chem: Conjugate.
14. Faiao-Flores F, Suarez JA, Maria-Engler SS, Soto-Cerrato V, Perez-Tomas R, Maria DA. The curcumin analog DM-1 induces apoptotic cell death in melanoma. Tumour Biol 2013, 34(2):1119-1129. 10.1007/s13277-013-0653-y, 23359272.
15. Wang WZ, Li L, Liu MY, Jin XB, Mao JW, Pu QH, Meng MJ, Chen XG, Zhu JY. Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells. Life Sci 2013, 92(6-7):352-358.
16. Zhang CY, Zhang L, Yu HX, Bao JD, Lu RR. Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression. Biotechnol Lett 2013, 35(7):995-1000. 10.1007/s10529-013-1173-y, 23474829.
17. Cheng TS, Chen WC, Lin YY, Tsai CH, Liao CI, Shyu HY, Ko CJ, Tzeng SF, Huang CY, Yang PC, et al. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cancer Prev Res (Phila) 2013, 6(5):495-505.
18. Liu L, Sun L, Wu Q, Guo W, Li L, Chen Y, Li Y, Gong C, Qian Z, Wei Y. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int J Pharm 2013, 443(1-2):175-182.
19. Masuelli L, Benvenuto M, Fantini M, Marzocchella L, Sacchetti P, Di Stefano E, Tresoldi I, Izzi V, Bernardini R, Palumbo C, et al. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. J Biol Regul Homeost Agents 2013, 27(1):105-119.
20. Choudhury D, Ganguli A, Dastidar DG, Acharya BR, Das A, Chakrabarti G. Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin. Biochimie 2013, 95(6):1297-1309. 10.1016/j.biochi.2013.02.010, 23485682.
21. Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano RJ, Anant S, Sharma P. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 2012, 7(2):e30590. 10.1371/journal.pone.0030590, 3281833, 22363450.
22. Han X, Xu B, Beevers CS, Odaka Y, Chen L, Liu L, Luo Y, Zhou H, Chen W, Shen T, et al. Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 2012, 33(4):868-875. 10.1093/carcin/bgs029, 3324444, 22298641.
23. Tu SP, Jin H, Shi JD, Zhu LM, Suo Y, Lu G, Liu A, Wang TC, Yang CS. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res (Phila) 2012, 5(2):205-215.
24. Quitschke WW. Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation. PLoS One 2012, 7(6):e39568. 10.1371/journal.pone.0039568, 3383725, 22768090.
25. Sahu RP, Batra S, Srivastava SK. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 2009, 100(9):1425-1433. 10.1038/sj.bjc.6605039, 2694438, 19401701.
26. Miller M, Chen S, Woodliff J, Kansra S. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology 2008, 149(8):4158-4167. 10.1210/en.2007-1760, 2488238, 18450960.
27. Milacic V, Banerjee S, Landis-Piwowar KR, Sarkar FH, Majumdar AP, Dou QP. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res 2008, 68(18):7283-7292. 10.1158/0008-5472.CAN-07-6246, 2556983, 18794115.
28. Bao B, Ali S, Banerjee S, Wang Z, Logna F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S, et al. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 2012, 72(1):335-345. 10.1158/0008-5472.CAN-11-2182, 22108826.
29. Kelly PN, Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 2011, 18(9):1414-1424. 10.1038/cdd.2011.17, 3149740,3149740, 21415859.
30. Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 2011, 30(18):3667-3683. 10.1038/emboj.2011.307, 3173800, 21863020.
31. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007, 87(1):99-163. 10.1152/physrev.00013.2006, 17237344.
32. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19(1):107-120. 10.1038/cdd.2011.96, 3252826, 21760595.
33. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993, 4(6):327-332.
34. Lindsay J, Esposti MD, Gilmore AP. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochim Biophys Acta 2011, 1813(4):532-539. 10.1016/j.bbamcr.2010.10.017, 21056595.
35. Walensky LD. BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 2006, 13(8):1339-1350. 10.1038/sj.cdd.4401992, 16763614.
36. Plumb JA. Cell sensitivity assays: the MTT assay. Methods Mol Med 2004, 88:165-169.
37. Dong P, Zhang Y, Gu J, Wu W, Li M, Yang J, Zhang L, Lu J, Mu J, Chen L, et al. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. J Ethnopharmacol 2011, 137(3):1373-1380. 10.1016/j.jep.2011.08.005, 21855619.
38. Quan Z, Gu J, Dong P, Lu J, Wu X, Wu W, Fei X, Li S, Wang Y, Wang J, et al. Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells. Cancer Lett 2010, 295(2):252-259. 10.1016/j.canlet.2010.03.008, 20359814.